Results 111 to 120 of about 197,407 (308)

Engineering Tertiary Lymphoid Structures: Nanomedicine, Bioengineering, and Biomaterials for Precision Immunotherapy

open access: yesAdvanced NanoBiomed Research, EarlyView.
This review explains how biomaterials and nanoparticles can be used to induce or modulate tertiary lymphoid structures (TLSs), which are ectopic immune hubs that form in nonlymphoid tissues during chronic disease and cancer. By comparing different methods, the article highlights design principles for modeling TLSs or recapitulating specific TLS ...
Shaza Karaman, Mei ElGindi, Jeremy Teo
wiley   +1 more source

Mannose‐Modified Cationic Liposome‐Based mRNA Therapeutics for Improved Triple‐Negative Breast Cancer Immunotherapy

open access: yesAdvanced NanoBiomed Research, EarlyView.
Schematic illustration of mTEM8‐loaded cationic liposome (cLipo‐Man/mTEM8) therapeutics for improved triple‐negative breast cancer immunotherapy. Despite triple‐negative breast cancer (TNBC) is the most heterogeneous and aggressive subtype of breast cancer, immunotherapy is emerging as a promising therapy.
Kexin Deng   +10 more
wiley   +1 more source

A Practical Method to Prevent Cross-Infection When Performing Dermoscopy

open access: yesDermatology Practical & Conceptual, 2021
Mohammed AlJasser
doaj   +1 more source

Impact of Climate Change on Reservoir Operation during the Dry Season in the Pearl River Basin [PDF]

open access: gold, 2023
Jin Liu   +6 more
openalex   +1 more source

Preclinical Safety Assessment of the EBS-LASV Vaccine Candidate against Lassa Fever Virus

open access: yesVaccines
There are currently no prophylactic vaccines licensed to protect against Lassa fever caused by Lassa virus (LASV) infection. The Emergent BioSolutions (EBS) vaccine candidate, EBS-LASV, is being developed for the prevention of Lassa fever.
Demetrius Matassov   +14 more
doaj   +1 more source

Development and validation of a 6-plex Luminex-based assay for measuring human serum antibodies to group B streptococcus capsular polysaccharides

open access: yesHuman Vaccines & Immunotherapeutics
Six serotypes (Ia, Ib, II, III, IV, and V) cause nearly all group B streptococcal (GBS) disease globally. Capsular polysaccharide (CPS) conjugate vaccines aim to prevent GBS disease, however, licensure of a vaccine would depend on a standardized ...
Michelle A. Gaylord   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy